During the past decade, Millennium Research & Clinical Development conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Millennium Research & Clinical Development" #1 sponsor was "Novartis Pharmaceuticals" with 4 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Millennium Research & Clinical Development" #1 collaborator was "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Millennium Research & Clinical Development" are "Adenocarcinoma" (1 trials), "Advanced Breast Cancer" (1 trials), "Advanced, Metastatic Breast Cancer" (1 trials), "Breast Cancer" (1 trials) and "Bronchial Diseases" (1 trials). Many other conditions were trialed in "Millennium Research & Clinical Development" in a lesser frequency.

Most popular intervention types in "Millennium Research & Clinical Development" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Ribociclib" (3 trials), "Fulvestrant" (2 trials), "Gemcitabine" (2 trials), "Goserelin" (2 trials) and "Letrozole" (2 trials). Other intervention names were less common.

The vast majority of trials in "Millennium Research & Clinical Development" are 7 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Millennium Research & Clinical Development". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Millennium Research & Clinical Development, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Millennium Research & Clinical Development, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".